Clinical Trial Update: SBRT Plus vNKT for Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SBRT plus vNKT therapy for pancreatic cancer is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• SBRT (stereotactic body radiotherapy)
• vNKT

Snippet

Sponsor: Changhai Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN